Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038358 (
gastric ulcer
)
5,179
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A controlled prospective study was undertaken to determine if fluids which bathe malignancies may contain
carcinoembryonic antigen
(
CEA
) earlier in the course of gastrointestinal cancer than does plasma of the same patient and may offer a better means for diagnosis.
CEA
titers were normal (less than 2.5 ng per ml) in the plasma of 42 healthy volunteers. Normal
CEA
levels were also found in the plasma and in the colonic mucus of 14, the gastric juice of 18, duodenal drainage of 10, and bile of 11 normal control subjects. The colonic mucus of 3 patients with ulcerative colitis, gastric secretions of 5 benign
gastric ulcer
patients, bile specimens from 11 normal control subjects and from 5 gallstone patients contained
CEA
at concentrations below 2.5 ng per ml. Positive
CEA
titers were found in the fluids bathing tumors of all 23 patients with colonic carcinoma, 9 of 17 patients with gastric carcinoma, and all 6 patients with pancreatic carcinoma. In contrast, positive
CEA
titers were found in the plasma of only 16 of 23 patients with colon carcinoma, 6 of 17 patients with gastric carcinoma, and 4 of 6 patients with pancreatic carcinoma. Among 46 patients with gastrointestinal malignancies,
CEA
was detected in significant concentrations in the plasma of 26 patients and in fluids bathing tumors of 38 patients. These results indicate a significant association of adenocarcinoma of the colon with
CEA
-positive colonic mucus (P less than 0.01) and suggest the usefulness of assaying
CEA
in fluids bathing tumors for the detection of gastrointestinal malignancies.
...
PMID:CEA levels in fluids bathing gastrointestinal tumors. 125 36
Radioimmunologic assays of blood serum
carcinoembryonic antigen
(
CEA
) level were conducted at major stages of treatment of gastric cancer by subtotal stomach resection and gastrectomy with preliminary cryotreatment and thawing of tumor. A short-term rise in
CEA
level occurred in 53.9% of cases 3-4 days after combined therapy. A decrease in
CEA
concentration at discharge from hospital as compared with preoperative level and that registered 3-4 days after operation was observed in 50 and 75% of cases of combined therapy, respectively, and 47.5 and 37.5% of controls (surgery without cryotreatment). There was no correlation between cryotreatment and changes in
CEA
level in
gastric ulcer
patients.
...
PMID:[Dynamics of carcinoembryonic antigen in patients with stomach cancer during treatment with cryotherapy]. 371 72
To clarify the significance of immunoreactive
carcinoembryonic antigen
in gastric juice (gastric CEA) from gastric cancer patients, we studied the gastric CEA in comparison with cancer progress, histologic types of tumors, staining for CEA and extent of intestinal metaplasia. The gastric CEA levels from patients with other gastric diseases, i.e.,
gastric ulcer
, duodenal ulcer and chronic gastritis were also investigated. The mean gastric CEA level from gastric cancer patients was significantly higher than from gastric or duodenal ulcer patients, but there was no significant difference between levels in patients with gastric cancer and in those with chronic gastritis. The gastric CEA levels from cancer patients increased with progression of the cancer. The differentiated carcinomas showed significantly higher gastric CEA levels than the poorly differentiated carcinomas. Positive CEA tumors showed significantly higher gastric CEA levels than did the negative CEA tumors. The tumors with diffuse intestinal metaplasia revealed high gastric CEA levels. Determination of gastric CEA levels is considered to be useful for screening of gastric cancer.
...
PMID:Immunoreactive carcinoembryonic antigen in gastric juice in patients with gastric cancer. 635 92
In order to ascertain the role of gastric
carcinoembryonic antigen
(
CEA
) determination in detecting patients with a risk for gastric cancer, 69 subjects were studied; 23 were referred for endoscopy because of dyspepsia but without obvious macroscopic lesions, 27 with duodenal ulcer, 11 with benign
gastric ulcer
, 8 with gastric cancer. The following results were obtained by subdividing the material according to the histologic interpretation of the results of gastric mucosal biopsies: (1) in the presence of minor histologic abnormalities of the gastric mucosa,
CEA
in gastric juice was under 100 ng/ml in all but five cases; and (2) in moderate or severe chronic atrophic gastritis (associated or otherwise with intestinal metaplasia or dysplasia), and in gastric cancer, gastric
CEA
ranged between 224 and 3120 ng/ml in all but two cases. Although not diagnostic for gastric cancer, gastric
CEA
is a promising test in detecting patients at risk, including those with dysplasia of the gastric mucosa.
...
PMID:Carcinoembryonic antigen in gastric juice collected during endoscopy. Value in detecting high-risk patients and gastric cancer. 664 May 4
The results of an endoscopic study of the incidence of gastritis and gastric cancer in
gastric ulcer
in a series of 112 patients 1 to 4 years (mean 2.6 years) after the initial examination are presented. Chronic antral gastritis was found in 48 % of cases and was mainly atrophic. In 10 cases both the antral and body mucosa were normal. In 11 cases the antral mucosa was normal before treatment and remained normal in most of them. During the observation period 5 patients died from other than gastrointestinal diseases. Eleven patients were operated on for complications or relapses of ulcer disease. Gastric cancer was found in 4 cases, the interval between the diagnoses of benign ulcer and cancer was from 1 to 27 months. Elevation of the blood
carcinoembryonic antigen
(
CEA
) level was found in 17 cases out of 56 examined and these values remained elevated in most cases at re-examination 3 years later.
...
PMID:Gastric ulcer, gastritis and gastric carcinoma. 727 Dec 22
The results of treating 12 consecutive patients with unresectable colorectal hepatic metastases with a hepatic arterial infusion of high-dose Adriamycin, 100-120 mg/m2, using hepatic venous isolation (HVI) and charcoal hemoperfusion (CHP) are reported herein. Adriamycin was administered over 5-15 min under extracorporeal drug elimination by HVI-CHP. HVI was percutaneously accomplished by either the double-balloon technique using a Fogarty occlusion catheter (8/22F) or a balloon-tipped catheter (16F). During the infusion, isolated hepatic venous blood was filtered by CHP and pumped into the left axillary vein. There were no lethal complications, and good hemodynamic tolerance to HVI-CHP was confirmed. Tumor liquefaction accompanied by a sharp decrease in serum
carcinoembryonic antigen
levels by more than 50% of pretreatment levels was observed in 6 of the 12 patients 1 month after treatment. Apart from chemical hepatitis, which developed in 11 (92%) of the patients, the Adriamycin toxicities were well controlled following the development of nausea and vomiting in 2 patients (17%), leukopenia < 2,000/mm3 in 3 (25%), and
gastric ulcer
in 1 (8%). These results indicate that this method is a safe and useful procedure for otherwise hazardous high-dose intra-arterial chemotherapy in patients with unresectable hepatic tumors.
...
PMID:Percutaneous hepatic venous isolation and extracorporeal charcoal hemoperfusion for high-dose intraarterial chemotherapy in patients with colorectal hepatic metastases. 872 14
Gastric ulcer
secondary to direct invasion from pancreatic adenocarcinoma is rare. Metastases to the stomach have been commonly reported with melanoma and with primary tumors of the breast, lung, ovary, liver, colon and testis. We report a patient who presented with epigastric pain and in whom subsequently upper endoscopy showed a malignant
gastric ulcer
secondary to direct invasion from pancreatic adenocarcinoma of the body. An 81-year-old female presented to our hospital with epigastric pain and subsequently underwent endoscopy with endoscopic ultrasound for evaluation of a pancreatic body mass. She had a large
gastric ulcer
in the fundus which was in direct continuity with the pancreatic mass. Pathology from biopsy of the ulcer revealed invasive well-to-moderately-differentiated adenocarcinoma, and immunohistochemical stains were strongly positive for CA19-9, CK7, CK19 and
carcinoembryonic antigen
. These findings were consistent with a histopathological diagnosis of metastatic carcinoma of the pancreas. Patients with gastrointestinal metastases usually have advanced malignancy with poor prognosis. Endoscopic evaluation with adequate biopsies should be performed for symptomatic patients.
...
PMID:Rare endoscopic manifestation of pancreatic adenocarcinoma. 2285 67
An elderly Thai woman had presented with dyspepsia and reflux symptoms since 6 years. Oesophagogastroduodenoscopy showed a large
gastric ulcer
with a histopathological diagnosis of signet ring cell carcinoma. The test for Helicobacter pylori was positive and it was successfully eradicated. An abdominal CT scan showed the irregularly thick antral wall along with non-specific subcentimeter lymph nodes which was compatible with at least stage IA. Her serum
carcinoembryonic antigen
level was within normal range. She refused any surgical treatment and preferred to take her own medications. To date, 6 years after her first diagnosis, the second oesophagogastroduodenoscopy was performed and showed a large
gastric ulcer
at the incisura extending to the gastric antrum. The histopathological result of the ulcer confirmed the presence of poorly differentiated adenocarcinoma with signet ring cell. She remains healthy and refused to have a follow-up disease staging or additional treatment.
...
PMID:A non-progressive signet patient with ring cell gastric adenocarcinoma who survived for 6 years without treatment. 2384 20
Activated platelets are involved in cancer development and progression. Mean platelet volume (MPV) and platelet distribution width (PDW) are early indexes of platelet activation. The objectives of this study were to investigate the ability of MPV, PDW and
carcinoembryonic antigen
(
CEA
) individually or in combination, to distinguish between gastric cancer and
gastric ulcer
. The study involved 194 patients with gastric cancer, 191 patients with
gastric ulcer
, and 185 control subjects. Subjects' characteristics and hematologic tests data at initial diagnosis were collected. We found that MPV levels are significantly increased and PDW levels are significantly reduced in patients with
gastric ulcer
and in control subjects compared with those in gastric cancer. When the area under the curve (AUC) was used to analyze control subjects
versus
gastric cancer, the combination of PDW and
CEA
exhibited a significantly larger AUC of 0.939 (0.910-0.961) compared with the combination of MPV and
CEA
(
p
= 0.0045). When AUC was used to analyze
gastric ulcer
versus
gastric cancer, PDW alone had the high specificity (98.5%) and high sensitivity (97.4%). In conclusion, combined use of MPV, PDW and
CEA
can accurately distinguish gastric cancer from
gastric ulcer
and controls. Further studies in larger samples are warranted.
...
PMID:Mean platelet volume, platelet distribution width and carcinoembryonic antigen to discriminate gastric cancer from gastric ulcer. 2897 72